Unknown

Dataset Information

0

Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity.


ABSTRACT: Maintaining stemness of leukemic stem cells (LSCs) and reciprocal interactions between leukemia and stromal cells support leukemic progression and resistance to chemotherapy. Targeting the niche-based microenvironment is thus a new approach for leukemia therapy. Cordycepin is an analogue of adenosine and has been suggested to possess anti-leukemia properties. However, whether cordycepin influences association of leukemia and mesenchymal stromal cells has never been investigated. Here we show that cordycepin reduces CD34+CD38- cells in U937 and K562 cells and induces Dkk1 expression via autocrine and paracrine regulation in leukemia and mesenchymal stromal/stem cells (MSCs). Cordycepin suppresses cell attachment of leukemia with MSCs and downregulates N-cadherin in leukemia and VCAM-1 in MSCs. Moreover, incubation with leukemic conditioned media (CM) significantly induces IL-8 and IL-6 expression in MSCs, which is abrogated by cordycepin. Suppression of leukemic CM-induced VCAM-1 and IL-8 by cordycepin in MSCs is mediated by impairing NF?B signaling. Finally, cordycepin combined with an adenosine deaminase inhibitor prolongs survival in a leukemic mouse model. Our results indicate that cordycepin is a potential anti-leukemia therapeutic adjuvant via eliminating LSCs and disrupting leukemia-stromal association.

SUBMITTER: Liang SM 

PROVIDER: S-EPMC5339716 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity.

Liang Shu-Man SM   Lu Yi-Jhu YJ   Ko Bor-Sheng BS   Jan Yee-Jee YJ   Shyue Song-Kun SK   Yet Shaw-Fang SF   Liou Jun-Yang JY  

Scientific reports 20170307


Maintaining stemness of leukemic stem cells (LSCs) and reciprocal interactions between leukemia and stromal cells support leukemic progression and resistance to chemotherapy. Targeting the niche-based microenvironment is thus a new approach for leukemia therapy. Cordycepin is an analogue of adenosine and has been suggested to possess anti-leukemia properties. However, whether cordycepin influences association of leukemia and mesenchymal stromal cells has never been investigated. Here we show tha  ...[more]

Similar Datasets

| S-EPMC5096815 | biostudies-other
| S-EPMC8046071 | biostudies-literature
| S-EPMC4924641 | biostudies-literature
| S-EPMC7052295 | biostudies-literature
| S-EPMC10642488 | biostudies-literature
| S-EPMC4699086 | biostudies-literature
| S-EPMC10831336 | biostudies-literature
| S-EPMC3347654 | biostudies-literature
| S-EPMC8322774 | biostudies-literature
| S-EPMC4988914 | biostudies-literature